At 10.9% CAGR, Europe Medical Writing Market is Projected to be Worth US$ 2,729.01 Million by 2031 says Business Market Insights

According to Business Market Insights’ research, the Europe medical writing market was valued at US$ 1,196.87 million in 2023 and is expected to reach US$ 2,729.01 million by 2031, registering a CAGR of 10.9% from 2023 to 2031. Increasing demand for regulatory and clinical trial documentation and implementation of tools and artificial intelligence in medical writing are among the critical factors attributed to drive the Europe medical writing market.

The increasing demand for regulatory and clinical trial documentation driven by the rise of personalized medicine and biologics is expected to create ample opportunities in the medical writing market. As the healthcare industry shifts toward personalized treatments, the need for precise, tailored documentation that can meet regulatory requirements and support scientific communication rises unprecedentedly. The growth in biologics, gene therapies, and cell-based treatments presents a significant opportunity for medical writers with specialized knowledge in these fields.

Additionally, the increase in pharmaceutical companies and changing healthcare policies translate into the expansion of medical writing services in emerging economies such as India. With pharmaceutical companies increasingly conducting clinical trials in region such as Asia Pacific, a growing demand for writers who are familiar with local regulatory requirements and can create documentation in multiple languages is observed. Moreover, the digital transformation of the healthcare industry presents a growing opportunity for medical writers to create content for eHealth and digital health platforms, such as telemedicine and mobile health apps. As digital health technologies become mainstream, companies will need skilled writers to produce content that explains medical treatments, guidelines, and data clearly for both healthcare professionals and patients

On the contrary, insufficient skilled medical writers hamper the growth of Europe medical writing market.

Based on type, the Europe medical writing market is segmented into clinical writing, regulatory writing, scientific writing, and others. The clinical writing segment held 44.6% market share in 2023, amassing US$ 534.19 million. It is projected to garner US$ 1,262.55 million by 2031 to register 11.4% CAGR during 2023–2031.

By application, the Europe medical writing market is segmented into medical journalism, medical education, and medico marketing. The medical journalism segment held 60.8% share of Europe medical writing market in 2023, amassing US$ 727.60 million. It is projected to garner US$ 1,683.68 million by 2031 to expand at 11.1% CAGR from 2023 to 2031.

Based on end user, the Europe medical writing market is bifurcated into pharmaceutical and biotechnology companies and contract research organizations. The pharmaceutical and biotechnology companies segment held 70.9% market share in 2023, amassing US$ 848.43 million. It is projected to garner US$ 2,010.74 million by 2031 to register 11.4% CAGR during 2023–2031.

Based on country, the Europe medical writing market is categorized into Germany, the UK, France, Spain, Italy, and the Rest of Europe. Our regional analysis states that Germany captured 27.1% share of Europe medical writing market in 2023. It was assessed at US$ 324.17 million in 2023 and is likely to hit US$ 755.30 million by 2031, registering a CAGR of 11.2% during 2023 to 2031.

Key players operating in the medical writing market are Cactus Communications, Parexel International Corp, Certara Inc, Freyr LLC, Quanticate International Ltd, SIRO Clinpharm Pvt Ltd, ProPharma Group, Caidya, Wipro Ltd, SGS SA, Laboratory Corp of America Holdings, TUNECT, Indegene Ltd, Evidera, Syner-G BioPharma Group, EMTEX BV, BioAgile Therapeutics Private Limited, Tata Consultancy Services Ltd, InClin, and TransPerfect Life Sciences, among others.

Contact Us
Phone: +16467917070
Email Id: sales@businessmarketinsights.com